Shockwave Medical Is Down 50%. Is It a Buy?
ShockWave Medical (NASDAQ: SWAV) investors have had a turbulent ride since the company's initial public offering in March.
The stock nearly tripled in its first three months. Since then, though, shares have been cut in half.
Volatility is nothing new for young, small-cap companies, especially for ones like ShockWave, a medical device maker using new technology to treat heart disease. Still, sustained volatility can leave even the most experienced investors wondering: Is this a good time to buy ShockWave, or is there more trouble to come?
Source Fool.com
